Evidence map›Paper›PMID 34926733›Full record

ArticleRegenerative therapy2021

Fibronectin-coating enhances attachment and proliferation of mesenchymal stem cells on a polyurethane meniscal scaffold.

Raquel Arredondo, Francesco Poggioli, Santos Martínez-Díaz, María Piera-Trilla, Raúl Torres-Claramunt, Laura Tío, Joan C Monllau

Open access · goldAbstract read
In one paragraph

Article in Regenerative therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. TheAnatomy & cell biology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Raquel ArredondoIMIM (Hospital del Mar Medical Research Institute), C/ Dr. Aiguader 88, 08003 Barcelona, Spain.
Francesco PoggioliOrthopaedic Department, ICATME-Institut Universitari Quirón-Dexeus, Universitat Autònoma Barcelona, C/ Sabino de Arana 5-19, 08028 Barcelona, Spain.
Santos Martínez-DíazIMIM (Hospital del Mar Medical Research Institute), C/ Dr. Aiguader 88, 08003 Barcelona, Spain.
María Piera-TrillaIMIM (Hospital del Mar Medical Research Institute), C/ Dr. Aiguader 88, 08003 Barcelona, Spain.
Raúl Torres-ClaramuntIMIM (Hospital del Mar Medical Research Institute), C/ Dr. Aiguader 88, 08003 Barcelona, Spain.
Laura TíoIMIM (Hospital del Mar Medical Research Institute), C/ Dr. Aiguader 88, 08003 Barcelona, Spain.
Joan C MonllauIMIM (Hospital del Mar Medical Research Institute), C/ Dr. Aiguader 88, 08003 Barcelona, Spain.
Universitat Autònoma de Barcelona · ESHospital Del Mar · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPartial meniscectomy is one of the most common surgical strategy for a meniscal injury, but sometimes, patients complain of knee pain due to an overload in the ablated compartment. In these cases, implantation of tissue engineering scaffold could be indicated. Currently, two commercial scaffolds, based on collagen or polycaprolactone-polyurethane (PCL-PU), are available for meniscus scaffolding. In short term follow-up assessments, both showed clinical improvement and tissue formation. However, long-term studies carried out in PCL-PU showed that the new tissue decreased in volume and assumed an irregular shape. Moreover, in some cases, the scaffold was totally reabsorbed, without new tissue formation.Mesenchymal stem cells (MSCs) combined with scaffolds could represents a promising approach for treating meniscal defects because of their multipotency and self-renewal. In this work, we aimed to compare the behaviour of MSCs and chondrocytes on a PCL-PU scaffold

methodsWe isolated rabbit bone marrow MSCs (rBM-MSCs) from two skeletally mature New Zealand white rabbits and stablished the optimum culture condition to expand them. Then, they were seeded over non-coated and FN-coated scaffolds and cultured in chondrogenic conditions. To evaluate cell functionality, we performed an MTS assay to compare cell proliferation between both conditions. Finally, a histologic study was performed to assess extracellular matrix (ECM) production in both samples, and to compare them with the ones obtained with rabbit chondrocytes (rCHs) seeded in a non-coated scaffold.

resultsA culture protocol based on low FBS concentration was set as the best for rBM-MSCs expansion. The MTS assay revealed that rBM-MSCs seeded on FN-coated scaffolds have more cells on proliferation (145%; 95% CI: 107%-182%) compared with rBM-MSCs seeded on non-coated scaffolds. Finally, the histologic study demonstrated that rCHs seeded on non-coated scaffolds displayed the highest production of ECM, followed by rBM-MSCs seeded on FN-coated scaffolds. Furthermore, both cell types produced a comparable ECM pattern.

conclusionThese results suggest that MSCs have low capacity attachment to PCL-PU scaffolds, but the presence of integrin alpha5beta1 (FN-receptor) in MSCs allows them to interact with the FN-coated scaffolds. These results could be applied in the design of scaffolds, and might have important clinical implications in orthopaedic surgery of meniscal injuries.

Indexed as

AMT, allograft meniscus transplantationCMI, collagen meniscal implantECM, extracellular matrixFibronectinFN, fibronectinITS, Insulin Transferrin SeleniumMeniscal injuriesMesenchymal stem cellMNCs, mononuclear cellsMSCs, mesenchymal stem cellsPCL-PU, polycaprolactone-polyurethanePost-meniscectomy syndromePSR, picrosirius redrBM, rabbit bone marrowrCHs, rabbit chondrocytesRT, room temperatureScaffoldsTissue engineering

Identifiers

PMID34926733
PMCPMC8633527
OpenAlexW3215628248

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.